{"id":17777,"date":"2024-12-17T11:17:57","date_gmt":"2024-12-17T08:17:57","guid":{"rendered":"https:\/\/www.kariyer.net\/ik-blog\/?p=17777"},"modified":"2024-12-17T11:17:57","modified_gmt":"2024-12-17T08:17:57","slug":"pfizer-turkiyede-ust-duzey-atama-4","status":"publish","type":"post","link":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/","title":{"rendered":"Pfizer T\u00fcrkiye&#8217;de \u00dcst D\u00fczey Atama"},"content":{"rendered":"<p><strong>Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Liderli\u011fine Yal\u0131m Can Arslan atand\u0131.<\/strong><\/p>\n<p>2012 y\u0131l\u0131nda Orta Do\u011fu Teknik \u00dcniversitesi End\u00fcstri M\u00fchendisli\u011fi b\u00f6l\u00fcm\u00fcnden mezun olan Yal\u0131m Can Arslan, kariyerine t\u00fcketici elektroni\u011fi ve beyaz e\u015fya sekt\u00f6r\u00fcnde Yurt D\u0131\u015f\u0131 Sat\u0131\u015f ve Pazarlama M\u00fcd\u00fcr\u00fc olarak ba\u015flad\u0131, Kas\u0131m 2014\u2019te Pfizer T\u00fcrkiye\u2019ye Y\u00f6netici Aday\u0131 (MT) olarak kat\u0131ld\u0131. Ard\u0131ndan s\u0131ras\u0131yla Nadir Hastal\u0131klar \u00dclke \u00dcr\u00fcn M\u00fcd\u00fcr\u00fc, Pazar Eri\u015fim M\u00fcd\u00fcr\u00fc ve Pazar Eri\u015fim ve Fiyatland\u0131rma Lideri g\u00f6revlerini \u00fcstlenen Arslan; Upjohn i\u015f biriminin Pfizer\u2019den ayr\u0131lmas\u0131 ve Viatris firmas\u0131n\u0131n kurulmas\u0131 s\u00fcre\u00e7lerinde rol ald\u0131ktan sonra Mart 2021 itibar\u0131yla Viatris\u2019ten ayr\u0131larak bir giyilebilir teknoloji giri\u015fimi kurdu. Yal\u0131m Can Arslan, Eyl\u00fcl 2021 tarihinde tekrar Pfizer T\u00fcrkiye b\u00fcnyesine kat\u0131ld\u0131. Hastane \u0130\u015f Birimi\u2019nde T\u00fcrkiye ve Polonya\u2019dan sorumlu Lansman ve Ticari M\u00fckemmeliyet Lideri olarak \u00e7al\u0131\u015ft\u0131ktan sonra 2022\u2019de Pazar Eri\u015fim ve Fiyatland\u0131rma Direkt\u00f6r\u00fc olarak atand\u0131. Ocak 2024\u2019ten bu yana Pfizer T\u00fcrkiye Ticari Lideri olarak g\u00f6rev yapan Yal\u0131m Can Arslan, 1 Aral\u0131k 2024 itibar\u0131yla Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Lideri olarak yeni g\u00f6revine ba\u015flad\u0131.<\/p>\n<!-- templates\/buttons-placeholder.php -->\n<div class=\"da-reactions-outer TpostID17777\">\n\t    <div class=\"da-reactions-data da-reactions-container-async center\"\n         data-type=\"post\"\n         data-id=\"17777\"\n         id=\"da-reactions-slot-post-17777\">\n        <div class=\"da-reactions-static\">\n\t\t\t<img src=\"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/plugins\/da-reactions\/assets\/dist\/loading.svg\" alt=\"Loading spinner\" width=\"48\" height=\"48\" style=\"width:48px\" \/>\n        <\/div>\n    <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Liderli\u011fine Yal\u0131m Can Arslan atand\u0131. 2012 y\u0131l\u0131nda Orta Do\u011fu Teknik \u00dcniversitesi End\u00fcstri M\u00fchendisli\u011fi b\u00f6l\u00fcm\u00fcnden mezun olan Yal\u0131m Can Arslan, kariyerine t\u00fcketici elektroni\u011fi ve beyaz e\u015fya sekt\u00f6r\u00fcnde Yurt D\u0131\u015f\u0131 Sat\u0131\u015f ve Pazarlama M\u00fcd\u00fcr\u00fc olarak ba\u015flad\u0131, Kas\u0131m 2014\u2019te Pfizer T\u00fcrkiye\u2019ye Y\u00f6netici Aday\u0131 (MT) olarak kat\u0131ld\u0131. Ard\u0131ndan s\u0131ras\u0131yla Nadir Hastal\u0131klar \u00dclke \u00dcr\u00fcn M\u00fcd\u00fcr\u00fc, [&hellip;]<\/p>\n<!-- templates\/buttons-placeholder.php -->\n<div class=\"da-reactions-outer TpostID17777\">\n\t    <div class=\"da-reactions-data da-reactions-container-async center\"\n         data-type=\"post\"\n         data-id=\"17777\"\n         id=\"da-reactions-slot-post-17777\">\n        <div class=\"da-reactions-static\">\n\t\t\t<img src=\"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/plugins\/da-reactions\/assets\/dist\/loading.svg\" alt=\"Loading spinner\" width=\"48\" height=\"48\" style=\"width:48px\" \/>\n        <\/div>\n    <\/div>\n<\/div>\n","protected":false},"author":14,"featured_media":17778,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_elementor_edit_mode":"","_elementor_template_type":"","_elementor_data":"","_elementor_page_settings":null,"_elementor_conditions":[]},"categories":[18],"tags":[],"class_list":{"0":"post-17777","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atamalar"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.4 (Yoast SEO v26.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer T\u00fcrkiye&#039;de \u00dcst D\u00fczey Atama<\/title>\n<meta name=\"description\" content=\"Pfizer\u2019e 2014\u2019te Y\u00f6netici Aday\u0131 (MT) olarak kat\u0131lan Yal\u0131m Can Arslan, Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Lideri olarak atand\u0131.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer T\u00fcrkiye&#039;de \u00dcst D\u00fczey Atama\" \/>\n<meta property=\"og:description\" content=\"Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Liderli\u011fine Yal\u0131m Can Arslan atand\u0131. 2012 y\u0131l\u0131nda Orta Do\u011fu Teknik \u00dcniversitesi End\u00fcstri M\u00fchendisli\u011fi b\u00f6l\u00fcm\u00fcnden\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/\" \/>\n<meta property=\"og:site_name\" content=\"\u0130K Blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-17T08:17:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2024\/12\/YalimCan_Arslan_Pfizer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Edit\u00f6r\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Edit\u00f6r\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 dakika\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer T\u00fcrkiye'de \u00dcst D\u00fczey Atama","description":"Pfizer\u2019e 2014\u2019te Y\u00f6netici Aday\u0131 (MT) olarak kat\u0131lan Yal\u0131m Can Arslan, Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Lideri olarak atand\u0131.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/","og_locale":"tr_TR","og_type":"article","og_title":"Pfizer T\u00fcrkiye'de \u00dcst D\u00fczey Atama","og_description":"Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Liderli\u011fine Yal\u0131m Can Arslan atand\u0131. 2012 y\u0131l\u0131nda Orta Do\u011fu Teknik \u00dcniversitesi End\u00fcstri M\u00fchendisli\u011fi b\u00f6l\u00fcm\u00fcnden","og_url":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/","og_site_name":"\u0130K Blog","article_published_time":"2024-12-17T08:17:57+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2024\/12\/YalimCan_Arslan_Pfizer.jpg","type":"image\/jpeg"}],"author":"Edit\u00f6r","twitter_misc":{"Yazan:":"Edit\u00f6r","Tahmini okuma s\u00fcresi":"2 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#article","isPartOf":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/"},"author":{"name":"Edit\u00f6r","@id":"https:\/\/www.kariyer.net\/ik-blog\/#\/schema\/person\/6b3f6b632f2b68a6fee208770c94827d"},"headline":"Pfizer T\u00fcrkiye&#8217;de \u00dcst D\u00fczey Atama","datePublished":"2024-12-17T08:17:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/"},"wordCount":228,"publisher":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/#organization"},"image":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2024\/12\/YalimCan_Arslan_Pfizer.jpg","articleSection":["Atamalar"],"inLanguage":"tr"},{"@type":"WebPage","@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/","url":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/","name":"Pfizer T\u00fcrkiye'de \u00dcst D\u00fczey Atama","isPartOf":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#primaryimage"},"image":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2024\/12\/YalimCan_Arslan_Pfizer.jpg","datePublished":"2024-12-17T08:17:57+00:00","description":"Pfizer\u2019e 2014\u2019te Y\u00f6netici Aday\u0131 (MT) olarak kat\u0131lan Yal\u0131m Can Arslan, Pfizer T\u00fcrkiye Nadir Hastal\u0131klar Kategori Lideri olarak atand\u0131.","breadcrumb":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#primaryimage","url":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2024\/12\/YalimCan_Arslan_Pfizer.jpg","contentUrl":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2024\/12\/YalimCan_Arslan_Pfizer.jpg","width":900,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.kariyer.net\/ik-blog\/pfizer-turkiyede-ust-duzey-atama-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana sayfa","item":"https:\/\/www.kariyer.net\/ik-blog\/"},{"@type":"ListItem","position":2,"name":"Pfizer T\u00fcrkiye&#8217;de \u00dcst D\u00fczey Atama"}]},{"@type":"WebSite","@id":"https:\/\/www.kariyer.net\/ik-blog\/#website","url":"https:\/\/www.kariyer.net\/ik-blog\/","name":"\u0130K Blog","description":"\u0130nsan Kaynaklar\u0131, \u0130\u015f D\u00fcnyas\u0131 Blogu | Kariyer.net","publisher":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kariyer.net\/ik-blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/www.kariyer.net\/ik-blog\/#organization","name":"Kariyer.Net","url":"https:\/\/www.kariyer.net\/ik-blog\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/ik-blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2023\/01\/og-image1.jpg","contentUrl":"https:\/\/www.kariyer.net\/ik-blog\/wp-content\/uploads\/2023\/01\/og-image1.jpg","width":800,"height":800,"caption":"Kariyer.Net"},"image":{"@id":"https:\/\/www.kariyer.net\/ik-blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.kariyer.net\/ik-blog\/#\/schema\/person\/6b3f6b632f2b68a6fee208770c94827d","name":"Edit\u00f6r","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/ik-blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0c4fe6688343aed3693b15573beae12c08ace5565409d5ab7509bf9c115f458d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0c4fe6688343aed3693b15573beae12c08ace5565409d5ab7509bf9c115f458d?s=96&d=mm&r=g","caption":"Edit\u00f6r"},"url":"https:\/\/www.kariyer.net\/ik-blog\/author\/editor\/"}]}},"_links":{"self":[{"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/posts\/17777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/comments?post=17777"}],"version-history":[{"count":1,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/posts\/17777\/revisions"}],"predecessor-version":[{"id":17779,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/posts\/17777\/revisions\/17779"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/media\/17778"}],"wp:attachment":[{"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/media?parent=17777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/categories?post=17777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kariyer.net\/ik-blog\/wp-json\/wp\/v2\/tags?post=17777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}